RETROPRESS: Data Collection of Patients Treated With the ColonRing™ for the Creation of Circular Compression Anastomosis

Sponsor
novoGI (Industry)
Overall Status
Completed
CT.gov ID
NCT01301417
Collaborator
(none)
171
1
5.9
28.8

Study Details

Study Description

Brief Summary

The proposed study is a post marketing, observational, retrospective data collection intended to gather and record data on patients treated with the ColonRing™ device in routine clinical practice at a single center. The data will assist in further evaluating the performance of the ColonRing™ device in regards to the creation of a colorectal anastomosis.

Hypothesis:The performance of the ColonRing™, determined by the rate of complications, will be within the acceptable range reported in the literature for alternative treatment modalities.

Study Design

Study Type:
Observational
Actual Enrollment :
171 participants
Time Perspective:
Retrospective
Official Title:
a RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRing ™
Study Start Date :
Feb 1, 2011
Actual Primary Completion Date :
Aug 1, 2011
Actual Study Completion Date :
Aug 1, 2011

Arms and Interventions

Arm Intervention/Treatment
ColonRing™

Adult Patients who underwent a laparoscopic or open colorectal resection with the creation of an anastomosis using the ColonRing™ in routine clinical practice

Device: ColonRing™
Creation of a circular Compression Anastomosis
Other Names:
  • Compression Anaqstomosis Ring™(CAR™)27
  • Outcome Measures

    Primary Outcome Measures

    1. Rate of anastomotic leakage [2-mo post-op]

      The primary study outcome is the rate of anastomotic leakage. Anastomotic leakage is defined as evidence of a defect in the intestinal wall integrity at the anastomotic site leading to a communication between the intra and extra luminal compartments.

    Secondary Outcome Measures

    1. Rate of other device related complications and measures during hospitalization and post procedure: [2-mo post-op]

      The following complications will be examined for relation to the device: Bleeding. Stricture (either clinical evidence of a stricture or the inability to pass a 12 mm sigmoidoscope through the anastomosis in a procedure that does not include a diversion). Septic complication (including wound infection, pelvic infection, peritonitis, abscess). Readmission, re-operation, death within two months of the procedure. Extra colonic complications (including urinary infection, urinary retention, DVT, pneumonitis, pulmonary embolism, cardiac, injury to other organs - e.g. spleen, ureter)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patient was > 18 years old at time of procedure

    • Patient underwent an open or laparoscopic colorectal procedure with the creation of an anastomosis using the ColonRing™

    • Patient treated in routine clinical practice following marketing clearance of the device within the cleared intended use

    • Patient underwent his/her first follow-up visit within two months post-surgery

    Exclusion Criteria:
    • No exclusion criteria have been defined for this data collection.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Southern Regional Medical Center Riverdale Georgia United States 30274

    Sponsors and Collaborators

    • novoGI

    Investigators

    • Study Director: Eran Choman, Msc, novoGI

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    novoGI
    ClinicalTrials.gov Identifier:
    NCT01301417
    Other Study ID Numbers:
    • RETROPRESS
    First Posted:
    Feb 23, 2011
    Last Update Posted:
    Jun 5, 2013
    Last Verified:
    Jun 1, 2013

    Study Results

    No Results Posted as of Jun 5, 2013